.jpg "Sudoscan")
.jpg "Preview: Sudoscan")
Sudoscan
.jpg "Sudoscan")
SUDOSCAN Principle
SUDOSCAN provides an accurate assessment of sudomotor function:
The system measures the extent to which sweat glands can release chloride ions in response to electrochemical activation on the palms of the hands and soles of the feet (zones of highest sweat gland density).
SUDOSCAN provides an accurate assessment of sudomotor function:
The system measures the extent to which sweat glands can release chloride ions in response to electrochemical activation on the palms of the hands and soles of the feet (zones of highest sweat gland density).
The utility of SUDOSCAN has been demonstrated in:
- Neurology: for the assessment and follow-up of conditions such as neuropathic pain management, idiopathic neuropathies, Gougerot Sjögren, amyloidosis, Fabry disease etc.
- Diabetology: for the early detection of peripheral neuropathy and sweat gland dysfunction, useful for the prevention of diabetic foot complications.
- Oncology: for a quantitative assessment of chemotherapy-induced Neuropathy, allowing a better and informed decision.
- Follow-up: for patient management, longitudinal treatment follow-up and lifestyle interventions
A trusted technology
SUDOSCAN has similar results to reference tests such as: skin biopsy, QSART, or clinical scores like NIS-LL. The technology is backed by over 150 publications in international scientific journals.
The device is manufactured in France and the test is very sensible and highly reproducible.
SUDOSCAN Technology animation